MORF4L1P3: A Potential Drug Target for Mitochondrial and Proton Homeostasis

Target Name: MORF4L1P3

NCBI ID: G326593

MORF4L1P3

Other Name(s): MRG11 | mortality factor 4 like 1 pseudogene 3 | MORF4LP3 | Mortality factor 4 like 1 pseudogene 3

MORF4L1P3: A Potential Drug Target for Mitochondrial and Proton Homeostasis

MORF4L1P3 (Mrg11) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the MORF gene family, which encodes for proteins that are involved in the regulation of mitochondrial fusion and fusion-protoplasmic stress (MORF) events.

MORF4L1P3 is a 19 kDa protein that is expressed in the brain, heart, and kidneys. It is highly conserved, with a calculated pI of 11.92 and a predicted localization in the cytoplasm. MORF4L1P3 is also known as Mrg11, which is a potential drug target in the treatment of various diseases.

The MORF gene family encodes for a variety of proteins that are involved in the regulation of mitochondrial fusion and fusion-protoplasmic stress events. These proteins include MORF1, MORF2, MORF3, MORF4, and MORF6. MORF4L1P3 is a member of the MORF4 gene family, and is expressed in various tissues of the body.

MORF4L1P3 is involved in the regulation of mitochondrial fusion and fusion-protoplasmic stress events. Mitochondrial fusion is the process by which two mitochondria fuse to form a single mitochondria. This process is important for maintaining cellular energy metabolism and has been implicated in a variety of diseases, including neurodegenerative diseases, cardiomyopathies, and diseases associated with aging.

MORF4L1P3 is also involved in the regulation of proton homeostasis in the cell. Proton homeostasis refers to the maintaining of the proper levels of protons in the cell, which is important for a variety of cellular processes, including cell signaling, DNA replication, and protein synthesis. MORF4L1P3 is involved in the regulation of proton homeostasis by interacting with the protein known as H+-ATPase (H+-ATPase), which is a protein that is involved in the regulation of ion channels in the cell.

MORF4L1P3 is also involved in the regulation of cellular stress responses. cellular stress responses are important for the regulation of cellular processes that are critical for survival, such as DNA damage repair, cell death, and inflammation. MORF4L1P3 is involved in the regulation of cellular stress responses by interacting with the protein known as p62, which is a protein that is involved in the regulation of cellular stress responses.

MORF4L1P3 is also involved in the regulation of mitochondrial dynamics. Mitochondrial dynamics refer to the movement of mitochondria in the cell, including the fusion and fusion-protoplasmic stress events that are important for maintaining cellular energy metabolism. MORF4L1P3 is involved in the regulation of mitochondrial dynamics by interacting with the protein known as T-tubulin, which is a protein that is involved in the regulation of microtubules in the cell.

MORF4L1P3 is also involved in the regulation of cellular signaling pathways. cellular signaling pathways refer to the processes by which cells communicate with one another and with their environment to maintain cellular homeostasis. MORF4L1P3 is involved in the regulation of cellular signaling pathways by interacting with the protein known as FAK, which is a protein that is involved in the regulation of cellular signaling pathways.

MORF4L1P3 is also involved in the regulation of

Protein Name: Mortality Factor 4 Like 1 Pseudogene 3

The "MORF4L1P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MORF4L1P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets